Synonyms:
IL-17F, ML-1, ML1
Description:
Recombinant Human IL-17F
Uniprot Name:
Interleukin-17F
Molecular Weight:
Disulfide linked dimer 15.0/30.1 kDa (134/268 aa)
Physical State:
Lyophilized
Formulation:
Lyophilized from a sterile filtered aqueous solution containing 0.1% Trifluoroacetic Acid (TFA)
Purity:
≥ 95% by reducing and non-reducing SDS-PAGE
Biological Activity:
≤ 100 ng/ml, determined by production of IL-6 from murine NIH/3T3 cells.
Specific Activity:
≥ 1.0 × 10e4
Endotoxin Level:
≤ 0.1 EUs/μg
Amino Acid Sequence:
MRKIPKVGHT FFQKPESCPP VPGGSMKLDI GIINENQRVS MSRNIESRST SPWNYTVTWD PNRYPSEVVQ AQCRNLGCIN AQGKEDISMN SVPIQQETLV VRRKHQGCSV SFQLEKVLVT VGCTCVTPVI HHVQ
Reconstitution:
Centrifuge vial prior to opening. Add sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Please note that the addition of any carrier protein into this product may produce unwanted endotoxin. This depends upon the particular application employed. Further dilutions should be made in appropriate buffered solutions.
Storage/Stability:
Store as supplied at -20°C to -80°C for up to 1 year. Upon reconstitution, prepare working aliquots and store at -20°C to -80°C. It is recommended that a carrier protein such as 0.1% HSA or BSA is added for long term storage. Avoid repeated freeze-thaw cycles.
